Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1971

Apr 15, 2019

Cause of cancer is written into DNA of tumours, scientists find, creating a ‘black box’ for origin of disease

Posted by in categories: biotech/medical, sustainability

The cause of cancer is written into the DNA of tumours, scientists have discovered, in a breakthrough which could finally show how much disease is attributable to factors like air pollution or pesticides.

Until now the roots of many cancers have proved elusive, with doctors unable to tease out the impact of a myriad of carcinogenic causes which people encounter everyday.

Even with lung cancer, it is not known just how much can be attributed to smoking and how much could be linked to other factors, such as living by a busy road, or inhaling pollutants at work.

Continue reading “Cause of cancer is written into DNA of tumours, scientists find, creating a ‘black box’ for origin of disease” »

Apr 15, 2019

Israeli scientists ‘print’ world’s first 3D heart with human tissue

Posted by in categories: biotech/medical, materials

A team of Tel Aviv University researchers revealed the heart, which was made using a patient’s own cells and biological materials.

Read more

Apr 15, 2019

Israeli Researchers Print 3D Heart Using Patient’s Own Cells

Posted by in categories: biotech/medical, materials

Israeli researchers have printed a 3D heart using a patient’s own cells, something they say could be used to patch diseased hearts — and possibly, full transplants.

The heart the Tel Aviv University team printed in about three hours is too small for humans — about 2.5 centimeters, or the size of a rabbit’s heart. But it’s the first to be printed with all blood vessels, ventricles and chambers, using an ink made from the patient’s own biological materials.

Read more

Apr 14, 2019

New Kind of Cancer ‘Vaccine’ Teaches The Immune System to Destroy Tumours

Posted by in category: biotech/medical

Researchers have invented a new type of cancer immunotherapy by injecting tumours with a series of stimulants. The experimental therapy attracts the body’s own immune system’s attention, so it can come and destroy the cancerous masses.

The radical new approach has already shown promise in patients with an advanced form of non-Hodgkin’s lymphoma that resists conventional treatments, and is currently being tested on a variety of stubborn cancers.

The result can be described as turning the tumours into “cancer vaccine factories”, because attracting the body’s immune cells to the cancer site is a method known as in situ vaccination.

Continue reading “New Kind of Cancer ‘Vaccine’ Teaches The Immune System to Destroy Tumours” »

Apr 14, 2019

Dr. Oliver Harrison MD, MPH, CEO, Telefonica Innovation Alpha — IdeaXme — Ira Pastor

Posted by in categories: aging, biotech/medical, business, computing, disruptive technology, genetics, health, information science, innovation, internet

Apr 13, 2019

You Need Vitamin D to Live. How Could This Woman Survive With None in Her Blood?

Posted by in category: biotech/medical

She had a series of bone fractures, but when doctors did blood tests, the supplements she took for treatment were nowhere to be found.

Read more

Apr 13, 2019

Longevity Myth Busting — Aubrey de Grey

Posted by in categories: biotech/medical, life extension

Allison Duettmann challenges Aubrey De Grey with the top objections against longevity to be debunked and debated before opening up the floor to the public.

Aubrey de Grey, Ph.D.

Continue reading “Longevity Myth Busting — Aubrey de Grey” »

Apr 13, 2019

How to biohack your cells to fight cancer — Greg Foot

Posted by in categories: bioengineering, biotech/medical, genetics

Check out the science of biohacking, where biologists go into a patient’s genetic code and reprogram their immune system to recognize and fight cancer cells.

-

Continue reading “How to biohack your cells to fight cancer — Greg Foot” »

Apr 13, 2019

Sustained rescue of prefrontal circuit dysfunction

Posted by in categories: biotech/medical, neuroscience

A better understanding of the mechanisms underlying the action of antidepressants is urgently needed. Moda-Sava et al. explored a possible mode of action for the drug ketamine, which has recently been shown to help patients recover from depression (see the Perspective by Beyeler). Ketamine rescued behavior in mice that was associated with depression-like phenotypes by selectively reversing stress-induced spine loss and restoring coordinated multicellular ensemble activity in prefrontal microcircuits. The initial induction of ketamine’s antidepressant effect on mouse behavior occurred independently of effects on spine formation. Instead, synaptogenesis in the prefrontal region played a critical role in nourishing these effects over time. Interventions aimed at enhancing the survival of restored synapses may thus be useful for sustaining the behavioral effects of fast-acting antidepressants.

Science, this issue p. eaat8078; see also p. 129.

Read more

Apr 13, 2019

From medicine to nanotechnology: How gold quietly shapes our world

Posted by in categories: biotech/medical, chemistry, nanotechnology

The periodic table of chemical elements turns 150 this year. The anniversary is a chance to shine a light on particular elements – some of which seem ubiquitous but which ordinary people beyond the world of chemistry probably don’t know much about.

One of these is , which was the subject of my postgraduate degrees in chemistry, and which I have been studying for almost 30 years. In chemistry, gold can be considered a late starter when compared to most other metals. It was always considered to be chemically “inert” – but in recent decades it has flourished and a variety of interesting applications have emerged.

Read more